Search

Your search keyword '"Shen, Jingkang"' showing total 72 results
Start Over Author "Shen, Jingkang" Publisher american association for cancer research (aacr)
72 results on '"Shen, Jingkang"'

1. Supplementary Fig.S6 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Fig.S13 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table S9 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Fig.S11 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Table S2 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Fig.S2 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Table S16 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

8. Data from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Fig.S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table S3 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Table S14 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Table S3 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Table S12 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Fig.S3 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table S13 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Table S8 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Fig.S10 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Fig.S12 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Fig.S2 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table S15 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table S11 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

22. Materials and Methods from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table S14 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Table S6 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Table S5 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Fig.S9 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

27. Supplementary Fig.S5 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table S2 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table S9 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Fig.S6 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table S11 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Fig.S3 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Fig.S4 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Fig.S13 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

35. Data from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Fig.S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Fig.S1 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Fig.S8 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

39. Supplementary Table S7 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

40. Supplementary Fig.S4 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

41. Supplementary Table S5 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table S10 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

43. Supplementary Fig.S10 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table S12 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

45. Materials and Methods from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table S15 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

47. Supplementary Fig.S12 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table S6 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Table S16 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Fig.S5 from Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers

Author

Zhou, Wei, primary, Fang, Peng, primary, Yu, Dongan, primary, Ren, Hongyuan, primary, You, Meng, primary, Yin, Long, primary, Mei, Fei, primary, Zhu, Huikai, primary, Wang, Zhenzhen, primary, Xu, Hui, primary, Cao, Yuxia, primary, Sun, Xiaowei, primary, Xu, Xiaohong, primary, Bi, Jianjun, primary, Wang, Jin, primary, Ma, Lanping, primary, Wang, Xin, primary, Chen, Lin, primary, Zhang, Yongliang, primary, Cen, Xiaowei, primary, Zhu, Xi, primary, Lou, Liguang, primary, Liu, Datao, primary, Tan, Xiaoding, primary, Yang, Jinliang, primary, Meng, Tao, primary, and Shen, Jingkang, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results